Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Gene therapy in the early stages of retinal degeneration

MacLaren RE., (2024), The Lancet, 404, 911 - 913

Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration.

Borchert GA. et al, (2024), Ophthalmic Genet, 1 - 7

Genetic therapies and potential therapeutic applications of CRISPR activators in the eye.

Ng BW. et al, (2024), Prog Retin Eye Res

Investigating the impact of asymmetric macular sensitivity on visual acuity chart reading in choroideraemia.

Baffour-Awuah KA. et al, (2024), Ophthalmic Physiol Opt

An Open-Label Phase II Study Assessing the Safety of Bilateral, Sequential Administration of Retinal Gene Therapy in Participants with Choroideremia: The GEMINI Study.

MacLaren RE. et al, (2024), Hum Gene Ther

Robotising vitreoretinal surgeries.

Mi H. et al, (2024), Eye (Lond)

Gene Therapies in Clinical Development to Treat Retinal Disorders.

McClements ME. et al, (2024), Mol Diagn Ther

Retinal characteristics of female choroideremia carriers: Multimodal imaging, microperimetry and genetics.

Gocuk SA. et al, (2024), Ophthalmol Retina

Robot-Assisted Eye Surgery: A Systematic Review of Effectiveness, Safety, and Practicality in Clinical Settings.

Thirunavukarasu AJ. et al, (2024), Transl Vis Sci Technol, 13

In Silico CRISPR-Cas-Mediated Base Editing Strategies for Early-Onset, Severe Cone-Rod Retinal Degeneration in Three Crumbs homolog 1 Patients, including the Novel Variant c.2833G>A.

Shamsnajafabadi H. et al, (2024), Genes (Basel), 15

Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degeneration.

Yusuf IH. et al, (2024), Mol Ther

Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.

Lam BL. et al, (2024), Ophthalmology

A Prospective, Observational, Noninterventional Clinical Study of Participants With Choroideremia: The NIGHT Study.

Maclaren RE. et al, (2024), Am J Ophthalmol, 263, 35 - 49

IMPG2-Related Maculopathy.

Birtel J. et al, (2024), Am J Ophthalmol, 258, 32 - 42

Optical Coherence Tomography Feature of Retinoschisis in CRB1-Associated Maculopathy.

Bellingrath J-S. et al, (2024), JAMA Ophthalmol, 142, 158 - 161

CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues.

Salman A. et al, (2024), Int J Mol Sci, 25

A hypomorphic variant of choroideremia is associated with a novel intronic mutation that leads to exon skipping.

Waldock WJ. et al, (2024), Ophthalmic Genet, 1 - 8

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy.

Borchert GA. et al, (2024), Front Neurosci, 18

Retinal Focal Nodular Gliosis (Vasoproliferative Tumors) Have Varied Clinical Courses Requiring Tailored Management: A Case Series

Ie A. et al, (2024), Ocular Oncology and Pathology

Comment on Di Giosaffatte et al. A Novel Hypothesis on Choroideremia-Manifesting Female Carriers: Could CHM In-Frame Variants Exert a Dominant Negative Effect? A Case Report. Genes 2022, 13, 1268

Fry LE. and MacLaren RE., (2023), Genes, 14

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?